Mass spectrometry of advanced glycation end products (Q33229504)

24 July 2017

1 reference

title

Mass spectrometry of advanced glycation end products (English)

1 reference

24 July 2017

3

Pietro Traldi

1 reference

24 July 2017

Annunziata Lapolla

1

1 reference

24 July 2017

Elisa Basso

series ordinal

2

1 reference

24 July 2017

publication date

1 January 2005

1 reference

Advances in Clinical Chemistry

24 July 2017

published in

1 reference

24 July 2017

volume

40

1 reference

24 July 2017

page(s)

165-217

1 reference

Biochemistry and molecular cell biology of diabetic complications

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Advanced glycation endproducts in ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Advanced glycation end products: a Nephrologist's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Protein kinase C activation and the development of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Advanced glycation end-products: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modi

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Protein glycation and oxidative stress in diabetes mellitus and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Advanced glycoxidation. A new risk factor for cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Nutritional and toxicological aspects of the Maillard browning reaction in foods

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

The AGE-receptor in the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

A study on in vitro glycation processes by matrix-assisted laser desorption ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

The lysine glycation 1. A preliminary investigation on the products arising from the reaction of protected lysine and D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

The in vitro glycation of lysozyme and the influence of buffer concentration investigated by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Qualitative determination of specific protein glycation products by matrix-assisted laser desorption/ionization mass spectrometry Peptide mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Mass spectrometric approaches in structural identification of the reaction products arising from the interaction between glucose and lysine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Matrix-assisted laser desorption/ionization capabilities in the study of non-enzymatic protein glycation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Diabetes and mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Evidence for an increased glycation of IgG in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Impairment by glycation of immunoglobulin G Fc fragment function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Polyclonal immunoglobulin M: location of glycation sites

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Impaired agglutination of IgM resulting from non-enzymatic glycation in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Glycation of monoclonal antibodies impairs their ability to bind antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

The complexity of non-enzymatic glycation product sets of human globins.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

O-(2,3,4,5,6-Pentafluorobenzyl)oxime-trimethylsilyl ester derivatives for sensitive identification and quantitation of aldehydes, ketones, and oxoacids in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

The assay of methylglyoxal in biological systems byderivatization with 1,2-diamino-4,5-dimethoxybenzene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

An effective derivatization method for quantitative determination of glyoxal and methylglyoxal in plasma samples by gas chromatography/mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Lilly Lecture 1993. Glycation and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Circulating advanced glycation peptides in streptozotocin-induced diabetic rats: evidence for preferential modification of IgG light chains

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Advanced glycation end products and their recognition by macrophage and macrophage-derived cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Lysosomal Enzymes as Agents of Turnover of Soluble Cytoplasmic Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Accurate mass measurements by Fourier transform mass spectrometry in the study of advanced glycation end products/peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Effects of age and diabetes mellitus on the solubility of collagen from human skin, tracheal cartilage and dura mater

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Advanced glycation end products: a highly complex set of biologically relevant compounds detected by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Advanced glycation end-products/peptides: a preliminary investigation by LC and LC/MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Mass spectrometric study of in vivo production of advanced glycation end-products/peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940005-0

7 January 2021

10.1016/S0065-2423(05)40005-0

Identifiers

DOI

0 references

1 reference